Home Cart Sign in  
Chemical Structure| 439288-66-1 Chemical Structure| 439288-66-1

Structure of GW627368
CAS No.: 439288-66-1

Chemical Structure| 439288-66-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GW627368 is a potent and selective competitive antagonist of prostanoid EP4 receptor (Ki= 100 nM) with additional human TP receptor affinity (Ki= 150 nM).

Synonyms: GW 627368X

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GW627368

CAS No. :439288-66-1
Formula : C30H28N2O6S
M.W : 544.62
SMILES Code : O=C(NS(=O)(C1=CC=CC=C1)=O)CC2=CC=C(N(CC3=C4C(OCC)=C(C=CC=C5)C5=C3OCC)C4=O)C=C2
Synonyms :
GW 627368X
MDL No. :MFCD12912327

Safety of GW627368

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of GW627368

GPCR

Isoform Comparison

Biological Activity

Description
GW627368 (GW627368X) is a novel, potent, and selective competitive antagonist of the prostanoid EP4 receptor, also showing affinity for human TP receptors with pKi values of 7.0 and 6.8, respectively[1].

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293 cells 10nM–1μM Evaluate the effect of SR9009 on a luciferase reporter driven by the Bmal1 promoter PMC1751567
CHO K1 cells 1 µM Evaluate the effect of GW627368X as an EP4 receptor antagonist PMC2438971
Sheep tracheal epithelium 10 μM GW627368X inhibited short circuit current responses to lubiprostone, indicating EP4 receptors as a target for lubiprostone in sheep tracheal epithelium. PMC3031069
SUM149 cells 0.1, 1, 10 μM 72 hours GW627368X significantly inhibited the invasion of SUM149 cells in a dose-dependent manner starting at 0.1 μM, but only inhibited MDA-MB-231 cell invasion at higher concentrations. PMC2889924
CHO cells 10μM Evaluation of GW627368X antagonism at human prostanoid CRTH2, EP1, EP2, EP3, FP, and IP receptors, showing no significant antagonism at CRTH2, EP2, EP3, IP, and FP receptors. PMC1751567
Human pulmonary vein 10 µM 30 minutes GW627368X inhibited the relaxation of human pulmonary vein induced by PGE2 and EP4 agonists (ONO-AE1-329, L-902688). PMC2518470
Human pulmonary artery 10 µM 30 minutes GW627368X inhibited the relaxation of human pulmonary artery induced by PGE2 and EP4 agonists (ONO-AE1-329, L-902688). PMC2518470
Rat mesenteric lymphatic muscle cells (RMLMC) 10^-6 M and 10^-7 M 4 days GW627368X, as a selective prostanoid EP4 receptor antagonist, reversed the IL-1β-induced suppression of RMLMC contraction, restoring their physiological contractility. PMC4543611

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rat Rat isolated fore stomach and colon Tissue bath 1 µM Single dose Evaluate the inhibitory effect of GW627368X on lubiprostone-induced contractions in colon circular muscle PMC2438971

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.84mL

0.37mL

0.18mL

9.18mL

1.84mL

0.92mL

18.36mL

3.67mL

1.84mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories